Medications

FDA approves first new drug for ALS in decades

(HealthDay)—The first new drug to treat amyotrophic lateral sclerosis (ALS) in more than 20 years has been approved by the U.S. Food and Drug Administration.

Oncology & Cancer

991 used oregon's physician-aided dying law 1998 to 2015

(HealthDay)—Fewer than 1,000 residents have followed through since Oregon became the first state to permit physician-aided dying in 1997, according to a report published online April 6 in JAMA Oncology.

Neuroscience

Scientists discover urinary biomarker that may help track ALS

A study in Neurology suggests that analyzing levels of the protein p75ECD in urine samples from people with amyotrophic lateral sclerosis (ALS) may help monitor disease progression as well as determine the effectiveness of ...

Psychology & Psychiatry

Meditation benefits patients with ALS

An eight-week mindfulness-based meditation program led to improved quality of life and psychological well-being in clinical trial of patients with amyotrophic lateral sclerosis (ALS).

Neuroscience

Mercury in fish, seafood may be linked to higher risk of ALS

Eating fish and seafood with higher levels of mercury may be linked to a higher risk of amyotrophic lateral sclerosis (ALS), according to a preliminary study released today that will be presented at the American Academy of ...

page 39 from 40